Helminth Therapy for Immune-Mediated Inflammatory Diseases: Current and Future Perspectives

Area of Science:

• Immunology
• Gastroenterology
• Pulmonology

Background:

• Immune-mediated inflammatory diseases (IMIDs), including inflammatory bowel disease (IBD) and allergic asthma, stem from complex immune dysregulation.
• Environmental, genetic, and bacterial factors contribute to immune imbalance, leading to severe pathology and challenging treatments.

Purpose of the Study:

• To review the pathogenesis of IBD and allergic asthma.
• To summarize the therapeutic potential of helminths and their molecules in treating IMIDs.
• To explore the immunoregulatory mechanisms of helminth-derived molecules for novel therapeutic strategies.

Main Methods:

• Literature review focusing on the pathogenesis of IBD and allergic asthma.
• Analysis of studies on helminth therapy and helminth-derived molecules for IMIDs.
• Examination of immunoregulatory mechanisms induced by helminth-derived molecules.

Main Results:

• Helminths and their molecules possess significant immunoregulatory capabilities.
• Helminth-derived molecules offer a promising therapeutic avenue for IMIDs, distinct from direct helminth infection.
• Immune indexes can guide the use of helminth-derived molecules for targeted immunoregulation.

Conclusions:

• Helminth-derived molecules represent a novel therapeutic strategy for immune-mediated inflammatory diseases.
• Harnessing helminth immunoregulation provides a safer and more controlled approach to managing IBD and allergic asthma.
• Further research into helminth-derived molecules can lead to effective treatment regimens for IMIDs.